Stoner Subscription Box with New Glass Every Month

The best stoner subscription boxes come jam packed with new things to try every month, but have you found one that comes with a new glass piece every month? As well as a few other items like smoking accessories, smell proof bags, and collectibles, Hemper is known to add in a newly designed glass piece with each month’s box. It’s no wonder they are one of the most popular options when it comes to stoner subscription boxes. 

These subscription boxes are delivered to your doorstep on a monthly basis. Typically you can subscribe to a one, three, or six-month plan. In general, the longer plans offer discounted rates per box. This allows you to subscribe to the box and receive cool items at a lower cost.

The Benefits of A Stoner Subscription Box 

Stoner subscription boxes provide a few unique benefits to their subscribers. These benefits include convenience, secrecy, and the exploration of new and trendy items. Stoner subscription boxes bring you what you need without you having to leave the couch. They offer you everything you need to chill, delivered directly to your door.

Subscription boxes also offer you secrecy. The contents of the boxes are carefully concealed inside discreet packaging. You are the only person that needs to know what is inside of the package. The most important benefit provided to the subscriber of a stoner box is the chance to explore new products. 

These subscription boxes ship new and trendy smoking products to your doorstep every month. Most companies do not promote the contents of the box before shipping. Every month, new surprises await you, with different products at a rate that can only be found through using a subscription service. This allows you to try new things at a low cost.

The Best Stoner Subscription Boxes with New Glass Pieces

Hemper is one of the few stoner subscription boxes that includes a newly designed & curated glass piece every month regardless of how many months you subscribe for. With subscriptions ranging from $9.99/.month to $39.99/month, you will be sure to find something to fit your needs. The retail value of all items exceed $149+ and are shipped to you on the same day each month in discreet packaging.

Each box includes a premium glass piece, smoking essentials, and limited-edition smoking accessories. There are at least ten products in each month’s box. These products are shipped to your home at no cost, provided that you live in the United States. Non-U.S. subscribers will pay additional for shipping.

Each subscription box brings you new bongs for stoners, smoking essentials you may need to get through the month. This includes blunt wraps, rolling papers, and lighters. They can also include stickers, bong mats, and stash containers. Hemper brings you affordability and variety straight to your doorstep to help you try the latest smoking gear without leaving the couch.

Hemper Stoner Subscription Box

There are a few other stoner subscription boxes to choose from in the market, but not every company offers a new glass every month or designs the glass themselves. 

Whether you like to enjoy your sesh sometimes or often, Hemper has a subscription box for avid and once in a while smokers. Their boxes help determine what kind of products you would like to receive each month by letting you try new things. When you select a subscription service based on your preferences, you will find something you like and get to try limited edition accessories from the product innovators at Hemper.


A stoner subscription box is the best way to try new products at a low cost. The boxes will introduce you to new smoking accessories and provide you with the items you need to enjoy your sesh for the month, depending on how often you toke.

Regardless of the box you select, stoner subscription boxes offer a few distinct benefits. They offer secrecy, convenience, and the chance to try new products. Hemper includes accessories retailing over $149 for only $39.99 shipped to your door! Start ordering their boxes to collect one of their limited edition pieces. From a UFO bong to a Ninja rig, Hemper has got something for all connoisseurs. See how a stoner subscription box can offer the best value for your smoking accessory needs.


3 Canadian Licensed Producer Updates Investors Need To Know

3 Canadian Licensed Producer Updates Investors Need To Know

During the last quarter, the Canadian cannabis sector has come under the microscope of the investment community and the market is analyzing the long-term viability of several key  Canadian operators.

Over the next year, we expect to see further consolidation in the Canadian cannabis industry. We also expect to see an increase in the number of companies that are filing for bankruptcy and believe that the industry is reaching an inflection point.

Selectivity has never been more important than it is today in the cannabis industry and we tend to prefer companies that meet specific criteria. Today, we want to highlight 3 Canadian Licensed Producers (LPs) that have reported significant developments over the last quarter and believe that these are operators to be aware of.

Will Cannabis Beverages Turn the HEXO Story Around?

Last month, HEXO Corporation (HEXO.TO) (HEXO) made headlines after it reported to have advanced the strategic relationship that it has with Molson Coors (TAP.CN). The companies formed Truss Beverage Co. and introduced 5 cannabis beverage brands to the Canadian cannabis market.

Truss’ cannabis beverage portfolio includes a variety of CBD and THC products that are full of natural flavors and we are favorable on the diversity of the product line. Going forward, Truss plans to rollout one of the widest cannabis beverage portfolios to the Canadian market and we will monitor how the partnership is able to execute on a coast-to-coast growth strategy.

According to a new study from Truss Beverage, 71% of Canadians of legal age cite smoking as the primary barrier to consuming cannabis, with 74% saying the smell of cannabis on their clothing is an issue (based on the Cannabis Culture Report 2020: Cannabis Usage & Attitudes, DIG Insights, May 2020).

During the last year, HEXO has been under substantial pressure and we believe that the relationship with Coors could prove to be the catalyst that the Canadian cannabis producer needed. We believe that the relationship with Molson Coors is a key pillar of the HEXO opportunity and will monitor how it benefits both businesses over the long-term.

Aurora Cannabis: Appoints New CEO after US CBD Acquisition

2020 has been a roller coaster for Aurora Cannabis Inc. (ACB.TO) (ACB) and we believe that analysts are starting to question its ability to survive the current market environment. From the closing of facilities to divesting previously acquired assets, the last twelve months have been challenging for the Canadian cannabis producer.

A few months ago, Aurora Cannabis announced the acquisition of Reliva, a hemp-derived CBD product company in the US. The transaction includes a potential earn-out that is structured to align risk and reward between Aurora shareholders and Reliva management to focus on continued strong operational and financial execution.

When the deal was announced, Aurora Cannabis reported that it expects the transaction to be immediately accretive on an adjusted EBITDA basis and we will monitor how the acquisition supports the growth of the business. We continue to be cautiously optimistic with the CBD market due to the saturation of the industry and hope that Aurora knew what it was doing when it announced the deal.

Following the acquisition, Aurora Cannabis appointed Miguel Martin as CEO and we will monitor how he is able to drive the story forward. With Martin as CEO, Aurora Cannabis plans to execute a tactical growth strategy that is intended to grow Aurora’s leading market share in key profitable Canadian consumer categories, protect and enhance Aurora’s leading market share in Canadian medical cannabis, grow the international medical business, and build leading brands under Reliva in the US CBD market.

We continue to be cautiously optimistic with Aurora Cannabis and will monitor how the management team is able to cut costs and grow revenues. The name of the game for Aurora Cannabis is execution and we will be closely following the story from here.

Canopy Growth: Trying to Increase Market Share

Last year, Canopy Growth Corporation (WEED.TO) (CGC) was considered to be the leading player in the Canadian and in the global cannabis market. A lot has changed in the last year and the company is working to optimize the business through strategic growth projects and cost cutting initiatives.

In 2019, Canopy Growth announced the firing of Bruce Linton as its CEO and Chairman. Following the firing of Bruce, Canopy Growth announced the closure of several cultivation facilities and recorded a $743 million impairment charge in the fourth quarter. These developments represent a major change in strategy for the cannabis producer and we will monitor how it benefits the business over the long-term.

During the last few months, several broker-dealers downgraded and lowered price targets on Canopy Growth and we find this to be of significance. In the most recent quarter, Canopy Growth recorded a $1.3 billion net loss and this number was much higher than what analysts were forecasting.

Although the last few months have been challenging for the Canadian cannabis producer, the business has a bright future. With almost $2 billion of cash on the balance sheet, Canopy Growth is well positioned to survive a prolonged downturn, and this is an opportunity that we will continue to closely monitor.


Share - Facebook

Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Mon, 21 Sep 2020 11:44:11 +0000

Cannabis Global, Inc. (OTCMKTS:CBGL): Four Reasons to Take a Closer Look

Cannabis Global, Inc. (OTCMKTS:CBGL): Four Reasons to Take a Closer Look

We have made the case that we believe the bottom formed in the cannabis space in March of this year represents a cyclical bottom in an ongoing long-term structural bull expansion trend that has potentially decades in front of it. From that perspective, investors will be looking for opportunities to find early-stage long-term winners in the space now that could grant access to powerful returns over the long run.

With that basic framework in place, we take a look today at Cannabis Global, Inc. (OTCMKTS:CBGL), a leading cannabinoid products company with a number of interesting catalysts recently announced, imminently coming to fruition, and brewing under the hood.

“It’s been approximately one year since we reorganized the Company toward cannabinoid technologies and products,” commented CEO, Arman Tabatabaei.  “We have made substantial progress in our selected technology areas, and based on these innovations, we have designed a revolutionary set of products, which are now rolling out into the marketplace.  I am pleased to offer our investors and the industry the following summary of activities and insight into our direction for this new fiscal year.”

That brings us to the four key avenues of expansion we see right now in CBGL.

Key Diversification

The company recently put out an update that covers its most important developments over the past year.

One key point was its recent acquisition of a key stake in a fully licensed cannabis manufacturing and distribution business operation located in Lynwood, California, operating under the name Natural Plant Extract of California, Inc. (“NPE”).

This move gives the company exposure to a Type 7 California Manufacturing License as well as a California Distribution license. The stake cost them just over $2 million and stands to grant them a solid channel of financial performance, while diversifying the company’s exposure to the cannabis plant as a business commodity, including direct access to current revenue growth, which is important given the company’s current positioning.

In addition, as noted in the release, the acquisition represents a strategic horizontal expansion of the company’s core technologies beyond hemp and CBD into California’s legal recreational and medical cannabis sectors.

Key Innovations

Cannabis Global, Inc. (OTCMKTS:CBGL) has also been busy on the R&D side, developing important IP and proprietary technology.

To that end, in the past year, the company filed six provisional patent applications. In its release, the company noted that it feels the most important of these provisional patents have to do with new methods to produce highly loaded polymeric nanoparticles, powderization technologies for hemp extract containing honey, and the single-serving tableting technology for beverage infusion.

That technology sets the stage for the company’s recent expansion in products, including coffee pods and alcohol-substitute cocktail mixers.

In addition, the company also discovered a proprietary process to produce Tetrahydrocannabivarian (THCV) in commercial quantities, and it is currently involved in research to add to the evidentiary profile of THCV with a study using mice. Progress here could give CBGL something like a near monopoly on a potentially very marketable cannabinoid with big things ahead. As noted in its release, “During the year, the Company developed new methods to produce nanoparticles of THC-V and other cannabinoids filing provisional patents on both the methods and the particles produced.”

Cannabis Global, Inc. (OTCMKTS:CBGL) is also continuing its R&D program in the area of tablet technology for single-serving beverages having recently filed a provisional patent relative to these areas. As noted in its release, additional filings are expected over the coming weeks.

New Products

The company has also been very aggressive with the development and commercialization of new products in the hemp, cannabis, and CBD marketplace.

For example, during the year, the Company developed Hemp You Can Feel technology based on powdered water-soluble preparations developed by the Company.  Marketed in cocktail mixers, the Company believes this is the industry’s first real alcohol replacement technology. We are in the process of placing the alcohol mixers in a major distribution company to maximize our exposure to customers.

In addition, based on the technology innovations developed through the previous fiscal year, Cannabis Global has developed multiple innovative products with coffee, Kombucha, and cocktail mixer products currently being marketed. Additionally, the Company is in production for both its hemp-based sweetener products and its highly innovative THC-V tea product line.

Expanded Distribution

Finally, Cannabis Global, Inc. (OTCMKTS:CBGL) is marching toward expanded distribution for its expanding stable of commercially available products.

According to the company’s release, “Moving into the newly commenced fiscal year, the major emphasis of the Company is expanding distribution channels for the highly innovative product lines.  To this end, the Company has recently begun an affiliate marketing campaign and is now offering products on the Amazon and RXLeaf platforms.  The Company plans to also begin marketing its alcohol-free cocktail mixers on Amazon with two cocktail mixers SKUs delivered to Amazon this week.”

That suggests the R&D has an outlet in the form of new products ready for market, and those products have an outlet in the form of an expanding connection with interested end-market consumers.

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click here. In addition, this article is part of Networks. Read the Networks Disclaimer.

Published at Mon, 21 Sep 2020 06:13:58 +0000

Rubicon Organics to Commence Trading on the TSX Venture Exchange

Rubicon Organics to Commence Trading on the TSX Venture Exchange

Rubicon Organics Inc. (CSE:ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, is pleased to announce that further to its press release dated July 27, 2020, the Company has received final approval to list its common shares and 3,150,000 warrants of the Company on the TSX Venture Exchange (the “TSX-V”).

The common shares and warrants of the Company are expected to be voluntarily delisted from the Canadian Securities Exchange at the close of trading on September 21, 2020 and are expected to commence trading on the TSX-V at the opening of trading on September 22, 2020.  The Company’s common shares will continue to trade under the symbol “ROMJ” and its warrants will continue to trade under the symbol “ROMJ.WT”.

“Rubicon Organics is listing on the TSX-V to increase the liquidity of our common shares and raise our profile in the capital markets. Having recently closed an equity financing during very challenging market conditions, we have secured the balance sheet we require to execute on a very exciting pipeline of milestones which includes ramping production and revenue at our Delta, BC facility, expanding our distribution capabilities and investing in product innovation showcasing our super-premium and organic certified cannabis,” said Jesse McConnell, Chief Executive Officer.


Rubicon Organics Inc., through its wholly owned subsidiary Vintages Organic Cannabis Company Inc., is a licensed producer focused on cultivating and selling organic certified, premium cannabis from its flagship 125,000 sq. ft. state-of-the-art hybrid-greenhouse located on a 20-acre property in Delta, BC, Canada. The Company is focused on achieving industry leading profitability through the development of the brand identity Simply Bare™ Organic, that combines the sale of high-margin, premium organic products with low-cost sustainable production. The Company is currently ramping up to production capacity of 11,000 kg per year of organic certified and environmentally sustainable cannabis.


Margaret Brodie
Chief Financial Officer
Phone: +1 (437) 929-1964

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the Canadian Securities Exchange accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, and statements regarding the Company’s expectations of when its securities will be delisted from the CSE and when trading will commence on the TSX-V; the Company’s belief that listing on the TSX-V will provide it and its shareholders with advantages, including greater visibility and enhanced market access for Canadian and international investors; the Company’s belief that it will gain more exposure through a larger market by listing on the TSX-V; the Company’s intention of achieving industry leading profitability; and the Company’s belief that it will achieve an annual production run rate of approximately 11,000 kg of certified organic, premium and environmentally sustainable cannabis are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such words or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that its capital needs will be as currently projected. Risks and uncertainties associated with forward looking information in this press release include, among others, information or statements concerning the Company’s expectations of financial resources available to fund operations; Rubicon Organics’ limited operating history and lack of historical profits; obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the Company’s ability to obtain financing at reasonable terms though the sale of equity and/or debt commitments; the Company’s ability to attract and retain skilled staff; market competition; the products and technology offered by the Company’s competitors; that our current relationships with our suppliers, service providers and other third parties will be maintained; and the impact of the current global health crisis caused by the COVID-19 pandemic. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Primary Logo

Published at Fri, 18 Sep 2020 11:05:26 +0000

Compass’s Upsized IPO Financing Sends ‘Buy’ Signal For Sector

Compass’s Upsized IPO Financing Sends ‘Buy’ Signal For Sector

Just three days after Compass Pathways (US:CMPS) announced its IPO financing of $107.2 million, the company has upsized the offering.

Compass has increased i) the number of shares being offered (up to 7.5 million), ii) the price per American Depository Share ($17.00) and thus the total size of the financing – up to $127.5 million.

At least one notable Compass Pathways shareholder couldn’t resist trumpeting the news on Twitter.

Presumably, this is a reflection of very strong demand for CMPS. For investors who like to bet on IPOs right out of the starting blocks, we could see a real feeding frenzy when Compass commences full public trading on the NASDAQ.

For investors who don’t like chasing stocks on their IPO? Look for even better value for your dollars.

Compass Pathways can’t (and won’t) launch the whole psychedelic drug industry alone. If the market chases Compass itself up to a steep valuation, value investors are going to move further down the totem pole of public companies – seeking more “bang” for their buck.

We already alluded to this in our original coverage of the Compass IPO announcement.

a)  Improved market sentiment for psychedelics companies
b)  Increased M&A activity
c)  Trickle-down effect
Few market events excite investors more than a big IPO. Existing psychedelics investors will be more inclined to put new money into these stocks. Many new investors can be expected to be attracted to the sector.

We’re seeing an indication of that “improved market sentiment” already: Compass boosting its IPO financing by roughly 20% — and at a higher unit price.

Increased M&A activity and “a trickle-down effect” can be expected to follow.

New sectors don’t evolve in a straight line. Stock prices for psychedelic drug companies have been trading sideways (or lower) for the past several months.

Investors may look back on this (in hindsight) as an ideal entry window for the psychedelics space. All aboard before the train leaves the station!

Published at Fri, 18 Sep 2020 13:20:54 +0000

Namaste Debuts “VendorLink” Cannabis Accessory Marketplace Platform

Namaste Debuts “VendorLink” Cannabis Accessory Marketplace Platform

Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), a leading platform for cannabis products, accessories and education, announced today the launch of VendorLink, a proprietary marketplace platform for brands and vendors to upload and sell their cannabis accessory products to CannMart customers directly. The first brand to utilize VendorLink is Canada Puffin, a leading Canadian hardware company focused on premium handblown glass and natural maple pipes and accessories.

Namaste Technologies Inc. Logo (CNW Group/Namaste Technologies Inc.)

VendorLink allows brands and vendors to upload their product catalogue directly to, to be displayed alongside CannMart’s own accessory inventory. With an expanding national presence and a strong base of loyal repeat customers, CannMart is in a unique position to leverage its online real estate with like-minded industry partners looking to expand their reach and introduce a true marketplace experience in the cannabis accessory space. Brands and vendors interested in establishing a presence on and accelerating their growth using VendorLink can join the waiting list by visiting

“Having been first conceived two years ago, we are thrilled to present VendorLink as the answer for cannabis accessory vendors large and small, looking to introduce their products to a fresh, Canada-wide audience through via a marketplace model,” said Meni Morim, CEO of Namaste Technologies. “Our debut partner, Canada Puffin, is the perfect brand to celebrate this launch with, as a dedicated proponent of both cannabis and Canadian culture.”

Determined to raise Canada’s national profile as a leader in the cannabis accessory movement, Canada Puffin is the first leading brand to work with CannMart and establish their own VendorLink marketplace presence.

“Namaste’s VendorLink offers a great way for Canada Puffin to introduce our premium accessories to a new audience of dedicated, cannabis-positive Canadians,” said Dale Falkenstein, CEO of Canada Puffin. “We look forward to expanding our presence through the Namaste network and are excited to be featured within this marketplace amongst some of the most notable brands in the industry.”

Canada Puffin’s glass accessories are thoughtfully designed as art pieces, intended to be proudly displayed. Made with authentic, natural Canadian Maple, each unique piece depicts elements of Canadian heritage and culture throughout.

About Canada Puffin
Canada Puffin is committed to creating an open and inviting culture in the ever changing smoking landscape. Through its unique product designs, quality and presentation, it strives to reshape the perception of cannabis and the community.  For more information please visit:

About Namaste Technologies Inc.
Headquartered in Toronto, Canada, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The Company’s ‘everything cannabis store’,, provides medical customers with a diverse selection of hand-selected products from a multitude of federally-licensed cultivators, all on one convenient site. The Company also distributes licensed and in-house branded cannabis and cannabis derived products to recreational consumers in Canada through a number of provincial government control boards and retailing bodies. Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions.

Information on the Company and its many products can be accessed through the links below:

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.


View original content to download multimedia:

SOURCE Namaste Technologies Inc.

Cision View original content to download multimedia:

Incite Capital Markets, Eric Negraeff / Darren Seed, Meni Morim, CEO, Namaste Technologies Inc., Ph: 604.493.2004, Email: ir@namastetechnologies.comCopyright CNW Group 2020

Published at Fri, 18 Sep 2020 12:04:00 +0000

The Next Level for Cannabis Stocks (GRWG, CURLF, SGMD, APHA)

The Next Level for Cannabis Stocks (GRWG, CURLF, SGMD, APHA)

As we head into the upcoming election on November 3, investors should anticipate major shifts in market behavior.

The uncertainty surrounding this election is palpable, not just because of the intense polarization that marks our current political moment, but because of added uncertainty drawn from the fact that, in a recent Pew research poll, nearly 70% of republican voters said they would vote in person at the ballot box on election day while over 75% of democrats said they were likely to vote by mail.

As both parties work to lay down strategies to support the narrative around this transition that best aids their partisan cause, markets shiver in anticipation of widespread social disarray as both seek to delegitimize the other’s claim to the throne after January.

That could create a lot of capital motion in the weeks ahead, as big money managers scramble to diversify and capitalize on new themes. One of those new themes that could vacuum up a lot of wandering capital is in the cannabis space, as we run toward multiple new legalization votes on state ballots as well as the potential that a putative Biden administration might quickly move to decriminalize on a national level.

As such, we put together a list of some interesting stocks in the space that could represent strong opportunities for speculators over the coming period, including: GrowGeneration Corp (NASDAQ:GRWG), Curaleaf Holdings Inc (OTCMKTS:CURLF), Sugarmade Inc (OTCMKTS:SGMD), and Aphria Inc (NASDAQ:APHA).

GrowGeneration Corp (OTCMKTS:GRWG) trumpets itself as a company that, through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. Currently, GrowGen has 27 stores, which include 5 locations in Colorado, 5 locations in California, 2 locations in Nevada, 1 location in Washington, 4 locations in Michigan, 1 location in Rhode Island, 4 locations in Oklahoma, 1 location in Oregon, 3 locations in Maine and 1 location in Florida.

GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers.

GrowGeneration Corp (OTCMKTS:GRWG) just announced that it believes it has uncovered fraudulent attempts to manipulate the Company’s stock. On August 21, 2020, an organization calling itself “Hindenburg Research” published false and defamatory statements about certain Officers and Directors of the Company designed to provide a false impression to investors and to manipulate the market to benefit short sellers.

According to the release, GrowGen intends to collaborate with law enforcement and regulators to ensure that any criminal activity is investigated and prosecuted. GrowGen will be taking steps to ensure that the organization ceases and desists from all illegal and otherwise wrongful activity. GrowGen will vigorously defend the value of the Company on behalf of shareholders and investors.

The stock has suffered a bit of late, with shares of GRWG taking a hit in recent action, down about -6% over the past week.

GrowGeneration Corp (OTCMKTS:GRWG) managed to rope in revenues totaling $43.5M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 123%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($14.8M against $18.8M, respectively).

Curaleaf Holdings Inc (OTCMKTS:CURLF) operates as an integrated medical and wellness cannabis operator in the United States. Curaleaf Inc.’s Florida operations were the first in the cannabis industry to receive the Safe Quality Food certification under the Global Food Safety Initiative, setting a new standard of excellence.

It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles. The company also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations.

Curaleaf Holdings Inc (OTCMKTS:CURLF) most recently announced the grand opening of Curaleaf Brandon, the company’s 31st location in Florida. The new location, located at 846 E. Brandon Blvd, is the third new dispensary in the Tampa / St. Petersburg / Clearwater metropolitan area this quarter.

Curaleaf is committed to serving the growing base of 394,000 registered medical patients in Florida, which is one of the nation’s fastest-growing medical cannabis markets in the country. In August, the company opened new dispensaries in Clearwater (2081 Gulf to Bay Blvd.) and South Tampa (3030 W. Gandy Blvd.). The company’s strategic expansion in the Tampa Bay area will provide patients and caregivers expanded access to high-quality medical cannabis products, including Select, America’s #1 cannabis oil brand.

The stock has suffered a bit of late, with shares of CURLF taking a hit in recent action, down about -4% over the past week. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -19%.

Curaleaf Holdings Inc (OTCMKTS:CURLF) generated sales of $162.8M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 25.4% on the top line. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($167.2M against $176.4M, respectively).

Sugarmade Inc (OTCMKTS:SGMD) operates now mostly through its controlling stake in BudCars, a leading California cannabis delivery company that operates on a traditional retail model with consistent 45-50% gross margins on cannabis inventory.

Sugarmade’s BudCars model has been feasting on increasing market share during the pandemic for obvious reasons: cannabis consumers can order their favorite products and have them delivered right to the door in touchless convenience. That dynamic has presented SGMD shareholders with a dramatic boom over recent months.

Sugarmade Inc (OTCMKTS:SGMD), to further drive that boom, recently announced that it is submitting an application to the California Bureau of Cannabis Control to expand into cannabis cultivation as part of a strategic plan to partially verticalize its BudCars model, a process that management strongly believes will further increase the Company’s gross profitability over the long-term and provide a rapid potential path to branded product development. The Company has already secured a property containing a 5,000 square-foot indoor premium cannabis cultivation facility located in very close proximity to its Sacramento BudCars hub.

Jimmy Chan, CEO of Sugarmade, noted, “BudCars is a high margin, high-growth business. But it will still benefit from verticalization. Because we have access to our end-market consumer directly and we have cultivation expertise and a premium grow facility, an expansion into cultivation to connect the dots is a clearly advantageous move. In addition, because BudCars is a rapidly growing distribution channel, we will have a clear edge in the marketplace in terms of the capacity to establish our own branded cannabis product line.”

Even with that news, the action hasn’t really heated up in the stock, with shares moving net sideways over the past week.

Sugarmade Inc (OTCMKTS:SGMD) has been posting major growth updates on a regular basis over the past couple months as its BudCars model takes apparent flight. The rate of sales growth expected from the company in 2020 has walked up a steep ladder, with the latest guidance suggesting we could see it north of $30 million in annualized sales by year-end.

Aphria Inc (NASDAQ:APHA) has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market.

The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. “Rooted in our founders’ multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.”

Aphria Inc (NASDAQ:APHA) recently announced it has entered into a Strategic Supply Agreement with Canndoc Ltd., a subsidiary of InterCure Ltd. (TASE: INCR) (TASE: INCR.TA), one of Israel’s largest and most established medical cannabis producers.

According to the release, under the terms of the Agreement, Aphria will supply Canndoc with dried bulk flower over a two-year period, with the option to extend for two additional terms of two years each, and an option for an additional year after that if the parties agree to terms.  During the first two-year term and each additional term, if applicable, the Company will provide Canndoc with 3,000 kgs. of bulk dried flower, which will be processed into finished product, co-branded under the Aphria and Canndoc brand names, and sold exclusively within the Israeli market.

While this is a clear factor, it has been incorporated into a trading tape characterized by a pretty dominant offer, which hasn’t been the type of action APHA shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -4% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -3%.

Aphria Inc (NASDAQ:APHA) managed to rope in revenues totaling $152.2M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 18.4%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($497.2M against $170.4M).

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click here. In addition, this article is part of Networks. Read the Networks Disclaimer.

Published at Mon, 14 Sep 2020 05:31:44 +0000

Cannabis Global, Inc. (OTCMKTS:CBGL) Makes Bold Move into Sweetener Market

Cannabis Global, Inc. (OTCMKTS:CBGL) Makes Bold Move into Sweetener Market

Cannabis Global, Inc. (OTCMKTS:CBGL), a leading cannabinoid products company that recently underwent a name and ticker change (previously MCTC Holdings – MCTC), announced this morning that it has officially started full-scale production of its new Hemp You Can Feel™ Sweeteners product line.

The release notes that production got started earlier this week and that distribution will ramp up starting next week.

According to the release, the line is the first hemp and cannabinoid-rich product that provides beverage and food sweetening in a cloud-free, 100% water-soluble format without the use of chemicals, additives, or GMOs. Based on methods utilizing unique non-infused honeybee hemp and cannabinoid technologies, the product line provides the all-natural label consumers are increasingly demanding.

This marks a significant move for the company. According to a report published in May by Fortune Business Insights, the global sugar substitutes market size is projected to surpass $10 billion by the end of 2026. CBGL is plowing head-long into this market with something truly unique.

The Science

Cannabis Global, Inc. (OTCMKTS:CBGL) noted in its release that the science behind its Hemp You Can Feel™ Sweeteners is simple. But it’s also complex.

The simple part: the primary hemp infusion technology is performed by honeybees. The bees eat hemp extracts – that they like – and, in return, produce honey. Simple.

The complex part: this honey includes a complex hemp compound that represents an all-natural substance that can be processed by the company into powdered sweeteners using its own proprietary process.

The result is a 100% water-soluble product line that does not alter the taste of beverages or foods (other than sweetening), is completely dissolvable in cold and hot fluids, is rich in cannabinoids and hemp extracts, and contains no chemical additives, surfactants, or emulsifiers.

“Just over a year ago, we analyzed the available water-soluble food and beverage hemp infusion technologies and were unimpressed with the options. Most clouded beverages tasted simply horrible and the vast majority used unhealthy and unnatural chemicals,” commented Arman Tabatabaei, CEO of Cannabis Global, Inc. (OTCMKTS:CBGL).  “With the limited options, we set out to develop something better.  We have succeeded well beyond our expectations!  We are very pleased to announce today, that we began production of the revolutionary Hemp You Can Feel™ Sweetener Product lines and will begin shipment next week.”

This is Big

As noted above, the sweetener space is surging and already large. People who want to avoid processed sugar, dangerous additives, and corn syrup want a natural solution that still tastes sweet. The idea that hemp is the key ingredient and honeybees are the production factory provides a strong marketing backdrop for this new product.

We also like the fact that this isn’t an announcement about something far off in the future. It’s already happening now – the product is already being manufactured, and distribution will begin in a few days.

It’s also important to remember that Cannabis Global, Inc. (OTCMKTS:CBGL) already has an established relationship with Amazon for distribution – something that’s increasingly difficult to secure.

As far as the product definition, the release goes on to list a number of interesting versions that will be included:

  • Hemp You Can Feel™ Sugar – Organic sugar with Hemp You Can Fee™ Infusions
  • Hemp You Can Feel™ Sucralose Blend – Sucralose blend with Hemp You Can Feel™ Infusions
  • Hemp You Can Feel™ Stevia Blend – Stevia extract (Rebiana) with Hemp You Can Feel™ Infusions
  • Hemp You Can Feel™ aspartame blended with Hemp You Can Feel™ Infusions
  • Hemp You Can Feel™ saccharin blended with Hemp You Can Feel™ Infusions
  • Hemp You Can Feel™ Monk Fruit Sweetener – Monk Fruit Extract and Erythritol with Hemp You Can Feel™ Infusions (coming)
  • Hemp You Can Feel™ Non-Dairy Creamer – A non-dairy creamer blend with Hemp You Can Feel™ infusions (coming)
  • Hemp You Can Feel™ French Vanilla Non-Dairy Creamer – A non-dairy creamer blend with Hemp You Can Feel™ infusions (coming)
  • Hemp You Can Feel™ Non-Dairy Creamy Chocolate Creamer – A non-dairy creamer blend with Hemp You Can Feel™ infusions (coming)

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click hereIn addition, this article is part of Networks. Read the Networks Disclaimer.

Published at Tue, 15 Sep 2020 16:20:50 +0000

Tauriga Sciences Inc (OTCMKTS:TAUG): Nationwide Launch of Highly Anticipated Rainbow Pack Imminent

Tauriga Sciences Inc (OTCMKTS:TAUG): Nationwide Launch of Highly Anticipated Rainbow Pack Imminent

We have pointed out Tauriga Sciences Inc (OTCMKTS:TAUG) in the past as an interesting speculative opportunity in the CBD space, but one that perhaps needed a fresh catalyst to break through onto the radar for market participants.

This is probably one of the most interesting emerging companies in the space, with a ton of recent progress in terms of brand expansion, distribution network, product range, and partnerships. TAUG is also differentiated in terms of bioavailability and delivery mechanism – its main product is Tauri-Gum, chewing gum in a wide range of flavors infused with Cannabidiol (CBD), Cannabigerol (CBG), and Vitamin C and Zinc (which is a proven antiviral defense).

This chewing gum delivery system, from a scientific standpoint, is best-in-class, providing optimal bioavailability. The oral mucosa of the mouth, as it turns out, provides the most complete and effective channel for full delivery of health and wellness supplements, producing unmatched bioavailability compared to topicals or digested edibles.

The company has also recently inked deals with a variety of new distribution partners, launched an e-commerce sales portal, and expanded its accepted payment platform reach.

But there has been one big catalyst looming that market participants may have been waiting for: the full nationwide roll-out of its “Rainbow Pack” – a sampler product with all the flavors and supplements.

The Sundae

As it happens, that big day is finally upon us. According to a release out late last week from Tauriga Sciences Inc (OTCMKTS:TAUG), the company has confirmed that its highly anticipated upcoming product launch for the Rainbow Deluxe Sampler Pack will officially happen this Sunday, September 20.

The product will only be available on the company’s e-commerce platform (

According to the release, “the Company received notification from its contract manufacturer, Per Os Biosciences, LLC (“Per Os Bio”), that inventory for its 6thTauri-Gum™ flavor, Pear Bellini (“Immune Booster”), will arrive next week at its E-Commerce fulfillment facility.  There have been substantial levels of interest in the Rainbow Pack and the pre-sales (which commenced on July 28, 2020) have been very strong.  The Company is confident the launch of its Rainbow Pack will accelerate growth, with respect to its highest margin E-Commerce business segment.”

That’s the ice cream, hot fudge, and sprinkles.

Two Giant Cherries on Top

However, there were two other big announcements hidden within the company’s release that should be highlighted here if you’re looking for potential excitement ahead for the stock.

First, Tauriga Sciences Inc (OTCMKTS:TAUG) snuck in a bit of guidance by stating that “As of September 10, 2020, the Company has already generated record Quarterly E-Commerce sales – during this current operating Quarter (2ndFiscal Quarter 2021).”

In other words, the quarter ending on September 30, 2020, already looks like a good candidate for record growth. That’s our analytic leap and we don’t have any more information on this than anyone else. But wellness products are e-commerce-heavy in terms of sales, and the fact that the company’s e-commerce sales are heading for a record suggests some potential that we are already seeing an acceleration overall in the company’s sales growth data, which will hit after quarter-end.

But this leap isn’t so big after all because of the next cherry on the sundae: “Additionally, the Company is in the final stages of completing a major Joint Venture Partnership Agreement (“JVP Agreement”) to enhance both the profile and scale of this upcoming Rainbow Pack launch.  It is anticipated that this JVP Agreement will be mutually executed within days.”

This is even bigger. We would expect this to be some sort of announcement about a partner to help market and distribute the new monster product offering that launches Sunday. That means we might be setting up to see this company launch its biggest product ever AND on the widest roll-out scale ever AND with a major new marketing and distribution deal for the final week of the quarter.

If we are already potentially flirting with new record sales for the company this quarter, that could put it over the top. And it also frames a very strong kick-off to the December quarter data.

As we said at the outset, Tauriga Sciences Inc (OTCMKTS:TAUG) is a stock that has been looking for that extra-hot catalyst to push it into the market’s spotlight. We may be setting up for that now.

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click hereIn addition, this article is part of Networks. Read the Networks Disclaimer.

Published at Wed, 16 Sep 2020 16:10:21 +0000

Medipharm Labs International Growth Strategy Is Starting To Pay Off In A Big Way

Medipharm Labs International Growth Strategy Is Starting To Pay Off In A Big Way

MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) is a global leader in the cannabis extraction market that operates out of a Good Manufacturing Practices (GMP) facility with ISO standard-built clean rooms. The company represents a differentiated opportunity that specializes in the production of purified, pharmaceutical-quality cannabis oil and concentrates and advanced derivative products.

One of the ways that MediPharm has been able to stand out as an industry leader is through the continued delivery of sophisticated cannabinoid formulations in innovative formats with pharmaceutical level quality standards. The company provides a variety of services, depending on customer needs (i.e. formulation, sensory testing, processing, packaging, labelling, and distribution of cannabis extracts and advanced cannabinoid-based products) and we are favorable on how the story has advanced so far this year.

Through its wholesale and white label platforms, MediPharm has been capitalizing on the domestic and international cannabis oil market and has a leading position in this vertical. A few months ago, the company announced its first commercial export order to Australia, which recently started generating revenue, and completed the commercialization of its Australian extraction facility.

We believe that MediPharm is an opportunity that has been flying under the radar and is trading for a discount when compared to its peers. By gaining a first mover advantage in strategic international markets, MediPharm is positioning itself for long-term growth and we believe that the market discounts the growth potential that is associated with it.

Announces a Milestone with Avicanna

Last month, MediPharm Labs reported a major milestone and announced the completion of the production of a new product format, sublingual sprays, as part of its multi-faceted strategic pharmaceutical manufacturing agreement with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a leading biopharmaceutical company.

In the near future, the sprays will be available to Canadian medical patients through the Medical Cannabis by Shoppers online healthcare platform. The sprays will be marketed under Avicanna’s RHO Phyto™ medical brand and we will monitor how the product line generates traction with medical patients. The sprays are an attractive option for medical patients since they are optimized for increased absorption and faster onset when compared to basic MCT (medium-chain triglyceride) sublingual sprays.

One of the reasons we are favorable on the new product format is related to the amount of time it takes to feel the effects. There is a large portion of medical and recreational customers that want to consume cannabis in ways that are healthier and more discreet than smoking (i.e. vaping and consumables). The sprays meet these specific criteria and are placed under the tongue to provide rapid absorption into the bloodstream.

MediPharm stands out as a leader in the Canadian cannabis oil market and was selected by Avicanna due to its state-of-the-art GMP extraction and processing facility and its pharmaceutical-quality production capabilities. Avicanna is executing on a strategy to bring new and innovative and sustainable plant-derived cannabinoid-based products to market and expect MediPharm to be a beneficiary of this.

The relationship between the companies is designed to provide patients and the medical community with advanced product offerings that are backed by science, data and world-class quality standards. Avicanna has an attractive pipeline of formulations that it has developed over the past four years in collaboration with leading Canadian research institutions.

A few months ago, the companies entered into a three-year, multi-faceted agreement that involves production, domestic and international distribution, and intellectual property licensing. The spray product is the second set of products to be developed by MediPharm and we are favorable on the amount of time it takes MediPharm’s technical team to bring a product to market. The spray product took MediPharm one-month to bring to market and we believe that this is a testament to the strength of the team and the amount of human capital that is on it.

Under the manufacturing segment of the agreement with Avicanna, MediPharm Labs uses its specialized capabilities to produce Avicanna’s advanced RHO Phyto™ medical cannabis products and Pura Earth™ dermacosmetic topicals. The first product that was produced as part of the relationship was Rho Phyto’s Blood Orange flavoured Micro Drops, in both high CBD and medium CBD formula made from full spectrum cannabis distillate.

Going forward, the companies plan to bring additional products to market and we are favorable on the track record of success so far. Additional product formats such as topicals, capsules and transdermal patches, are being finalized for production under the contract manufacturing agreement and we expect to see additional product brought to market in the near future.

In late 2019, Health Canada approved the sale of cannabis derivative products like edibles, drinkables, vape pens, concentrates, sublinguals, topicals, tinctures, salves, and more. This represented a major transformation of the Canadian market and is referred to as cannabis 2.0.

We believe that MediPharm is well positioned to be a beneficiary of the cannabis 2.0 market and expect it to report strong growth from this vertical on a going forward basis. The completion of the second product with Avicanna highlights how the Canadian cannabis market has changed and how MediPharm is increasing market share in the contract manufacturing space.

One of the ways that the cannabis 2.0 market has impacted the entire Canadian industry is through the formation of a new consumer segment that is not price sensitive and will pay a premium price for quality products. We like to compare this group of consumers to the wine industry which has a large segment of wine connoisseurs and who pay a massive premium for certain brands.

Through contract manufacturing and white label agreements with brand leaders, as well as its growing portfolio of pharmaceutical quality products that are produced from its GMP-certified facilities in Canada and Australia, MediPharm is well positioned to capitalize on the changing landscape of the domestic and international cannabis market.

By the end of the second quarter, MediPharm Labs had 60 concentrate-based product SKUs in production for medical, wellness and recreational brands. Some of the products that are in the portfolio are high-potency formulated oils, vape cartridges, topicals and sublingual sprays. We are favorable on the amount of MediPharm owned or produced products that are on the market and expect this trend to become more significant in the back half of the year.

MediPharm continues to enhance its capabilities in product innovation and flexible manufacturing and we are favorable on how it continues to focus on improving the process. The business is supported by a distinguished team of researchers and production professionals that have decades of pharmaceutical experience and this is an attractive aspect of the story. The company is systematically executing on a multi-faceted growth strategy as a differentiated, international pharmaceutical company and partner to leading cannabis brands.

Pursuant to an agreement between StoneBridge Partners LLC and Medipharm Labs we have been hired for a period of 180 days beginning August 18, 2020 and ending March 18, 2020 to publicly disseminate information about (LABS) including on the Website and other media including Facebook and Twitter. We are being paid $6,000 per month (LABS) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero (0) shares of (LABS), which we purchased in the open market. We plan to sell the “ZERO” shares of (LABS) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LABS) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.


Share - Facebook

Share - Twitter

Published at Tue, 15 Sep 2020 11:35:44 +0000